MAP3K7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.647560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.171030E-01
Normal-vs-Stage2
1.933520E-02
Normal-vs-Stage3
5.483900E-02
Normal-vs-Stage4
7.090200E-01
Stage1-vs-Stage2
7.482400E-01
Stage1-vs-Stage3
2.851000E-01
Stage1-vs-Stage4
6.173600E-02
Stage2-vs-Stage3
1.440160E-01
Stage2-vs-Stage4
3.892400E-02
Stage3-vs-Stage4
3.204300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.359700E-02
Normal-vs-AfricanAmerican
2.360400E-01
Normal-vs-Asian
4.199700E-02
Caucasian-vs-AfricanAmerican
3.850800E-01
Caucasian-vs-Asian
2.100200E-01
AfricanAmerican-vs-Asian
1.861230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.752340E-02
Normal-vs-Female
2.331800E-02
Male-vs-Female
2.633000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.460200E-01
Normal-vs-Age(41-60Yrs)
3.745800E-02
Normal-vs-Age(61-80Yrs)
1.611590E-02
Normal-vs-Age(81-100Yrs)
5.189800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.636000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.635400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.985600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.999700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.952000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.014600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.731780E-02
Normal-vs-Daily Drinker
4.197000E-03
Normal-vs-Weekly Drinker
1.060970E-01
Normal-vs-Occasional Drinker
5.334300E-02
Normal-vs-Social Drinker
1.550380E-01
Non Drinker-vs-Daily Drinker
2.379400E-01
Non Drinker-vs-Weekly Drinker
5.072000E-01
Non Drinker-vs-Occasional Drinker
3.493800E-01
Non Drinker-vs-Social Drinker
1.350560E-01
Daily Drinker-vs-Weekly Drinker
1.209400E-01
Daily Drinker-vs-Occasional Drinker
4.638100E-02
Daily Drinker-vs-Social Drinker
1.709510E-02
Weekly Drinker-vs-Occasional Drinker
9.040600E-01
Weekly Drinker-vs-Social Drinker
5.321200E-01
Occasional Drinker-vs-Social Drinker
5.338200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.048200E-01
Normal-vs-Grade 2
8.017900E-02
Normal-vs-Grade 3
8.882200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.338000E-01
Grade 1-vs-Grade 3
9.434000E-02
Grade 1-vs-Grade 4
3.048200E-01
Grade 2-vs-Grade 3
2.673800E-01
Grade 2-vs-Grade 4
8.017900E-02
Grade 3-vs-Grade 4
8.882200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.626450E-02
Normal-vs-NonDiabetic
8.177000E-03
Diabetic-vs-NonDiabetic
9.887400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.178000E-01
Normal-vs-NoPancreatitis
1.222400E-02
Pancreatitis-vs-NoPancreatitis
3.385600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.791900E-02
Normal-vs-N1
1.596200E-02
N0-vs-N1
8.848200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.990200E-02
Normal-vs-TP53-NonMutant
4.799800E-02
TP53-Mutant-vs-TP53-NonMutant
5.495600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
